Fidia Valuation

Is FDA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of FDA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate FDA's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate FDA's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for FDA?

Key metric: As FDA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for FDA. This is calculated by dividing FDA's market cap by their current revenue.
What is FDA's PS Ratio?
PS Ratio	0.06x
Sales	€29.17m
Market Cap	€1.62m

FDA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.2x
Enterprise Value/EBITDA	-2.4x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does FDA's PS Ratio compare to its peers?

The above table shows the PS ratio for FDA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	0.4x
GEL Gel	0.7x	2.8%	€11.0m
VIM Vimi Fasteners	0.2x	5.3%	€14.7m
CLABO Clabo	0.3x	4.0%	€16.2m
MARP Marzocchi Pompe	0.4x	2.0%	€19.4m
FDA Fidia	0.06x	n/a	€1.6m

Price-To-Sales vs Peers: FDA is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (0.4x).

Price to Sales Ratio vs Industry

How does FDA's PS Ratio compare vs other companies in the IT Machinery Industry?

1 Company	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	0.7x	5.0%
FDA Fidia	0.06x	n/a	US$1.70m

No more companies available in this PS range

1 Company		Estimated Growth	Market Cap
Industry Avg.	0.7x	26.9%
FDA Fidia	0.06x	n/a	US$1.70m

No more companies

Price-To-Sales vs Industry: FDA is good value based on its Price-To-Sales Ratio (0.1x) compared to the Italian Machinery industry average (0.7x).

Price to Sales Ratio vs Fair Ratio

What is FDA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

FDA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.06x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate FDA's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

CNH Industrial

US$13.6b

An equipment and services company, engages in the design, production, marketing, sale, and financing of agricultural and construction equipment in North America, Europe, the Middle East, Africa, South America, and the Asia Pacific.

1CNHI

US$10.29

2.4%

8.7%

Fincantieri

€1.8b

Operates in the shipbuilding industry worldwide.

FCT

€5.65

-2.6%

6.0%

TREVI - Finanziaria Industriale

€90.7m

Operates in the soil engineering field.

TFIN

€0.29

1.2%

16.7%